Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.96 INR | +0.72% |
|
-1.00% | +26.55% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 105.6 | 185.3 | 355.3 | 170.8 | 79.86 | 46 |
Enterprise Value (EV) 1 | 118.4 | 220.6 | 368.7 | 226.8 | 271.6 | 130.9 |
P/E ratio | 20.6 x | 28.2 x | 67.6 x | 308 x | 15.8 x | 75.8 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.3 x | 0.24 x | 0.41 x | 0.25 x | 0.25 x | 0.24 x |
EV / Revenue | 0.34 x | 0.29 x | 0.43 x | 0.33 x | 0.86 x | 0.68 x |
EV / EBITDA | 10.3 x | 15.6 x | 28.9 x | 34.5 x | 32.8 x | 19.3 x |
EV / FCF | -13 x | -6.61 x | 18 x | -5.37 x | -2 x | 1.22 x |
FCF Yield | -7.7% | -15.1% | 5.57% | -18.6% | -50% | 81.8% |
Price to Book | 0.98 x | 1.5 x | 2.75 x | 1.33 x | 0.6 x | 0.35 x |
Nbr of stocks (in thousands) | 8,856 | 10,109 | 10,109 | 10,109 | 10,109 | 10,109 |
Reference price 2 | 11.92 | 18.33 | 35.15 | 16.90 | 7.900 | 4.550 |
Announcement Date | 8/31/18 | 9/5/19 | 12/8/20 | 9/8/21 | 9/8/22 | 9/8/23 |
Income Statement Evolution (Annual data)
Fiscal Period: Maart | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 350.7 | 763.1 | 865.1 | 692 | 315.4 | 191.2 |
EBITDA 1 | 11.49 | 14.14 | 12.73 | 6.575 | 8.277 | 6.8 |
EBIT 1 | 10.06 | 11.97 | 10.6 | 4.525 | 6.688 | 4.615 |
Operating Margin | 2.87% | 1.57% | 1.22% | 0.65% | 2.12% | 2.41% |
Earnings before Tax (EBT) 1 | 6.941 | 8.911 | 7.246 | 1.047 | 2.321 | 0.87 |
Net income 1 | 5.156 | 6.6 | 5.285 | 0.5555 | 5.101 | 0.655 |
Net margin | 1.47% | 0.86% | 0.61% | 0.08% | 1.62% | 0.34% |
EPS 2 | 0.5800 | 0.6500 | 0.5200 | 0.0550 | 0.5000 | 0.0600 |
Free Cash Flow 1 | -9.119 | -33.38 | 20.52 | -42.28 | -135.9 | 107.2 |
FCF margin | -2.6% | -4.37% | 2.37% | -6.11% | -43.1% | 56.03% |
FCF Conversion (EBITDA) | - | - | 161.11% | - | - | 1,575.78% |
FCF Conversion (Net income) | - | - | 388.18% | - | - | 16,359.29% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/31/18 | 9/5/19 | 12/8/20 | 9/8/21 | 9/8/22 | 9/8/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 12.8 | 35.3 | 13.3 | 56 | 192 | 84.9 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.115 x | 2.496 x | 1.047 x | 8.518 x | 23.17 x | 12.49 x |
Free Cash Flow 1 | -9.12 | -33.4 | 20.5 | -42.3 | -136 | 107 |
ROE (net income / shareholders' equity) | 5.33% | 5.7% | 4.18% | 0.43% | 3.9% | 0.5% |
ROA (Net income/ Total Assets) | 2.73% | 2.54% | 1.66% | 0.65% | 1.01% | 0.87% |
Assets 1 | 189 | 260.1 | 318.3 | 85.22 | 506.4 | 75.61 |
Book Value Per Share 2 | 12.20 | 12.20 | 12.80 | 12.70 | 13.20 | 12.90 |
Cash Flow per Share 2 | 1.410 | 0.5200 | 0.5300 | 0.6200 | 0.5600 | 0.6100 |
Capex 1 | 10.7 | 0.13 | 0.15 | 0.21 | 4.74 | 0.59 |
Capex / Sales | 3.05% | 0.02% | 0.02% | 0.03% | 1.5% | 0.31% |
Announcement Date | 8/31/18 | 9/5/19 | 12/8/20 | 9/8/21 | 9/8/22 | 9/8/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+26.55% | 844K | |
+19.99% | 67.97B | |
-6.03% | 45.92B | |
+22.27% | 43.74B | |
+33.20% | 28.16B | |
+8.15% | 19.17B | |
+14.71% | 17.12B | |
-13.18% | 14.73B | |
-27.99% | 14.52B | |
-32.33% | 11.64B |
- Stock Market
- Equities
- CHDCHEM6 Stock
- Financials Chd Chemicals Limited